Article
Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor…
bioRxiv · 2023 · Danny Wilbie
Key facts
| Title | Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out |
|---|---|
| First author | Danny Wilbie |
| Journal | bioRxiv |
| Published | Nov 9, 2023 |
| DOI | 10.1101/2023.11.09.566375 |
| Product codes mentioned | JJH, KIZ |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1